Arcadia Biosciences Inc expected to post a loss of 34  cents a share - Earnings Preview

Arcadia Biosciences

11/05/2022 02:23

* Arcadia Biosciences Inc  RKDA.OQ   RKDA.O  is expected
to show a
rise in quarterly revenue when it reports  results on May 12. 
    * The Davis California-based  company is expected to report 
a
129.3% increase in revenue to $1.899 million from $828 thousand
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Arcadia Biosciences
Inc
is for a loss of 34 cents per share. For the same quarter last
year, the company reported earnings of 12 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Arcadia
Biosciences Inc is $3.75​, above​ its last closing price
of $0.92. ​​​

This summary was machine generated May 11 at 01:23 GMT.  All
figures in US dollars  unless otherwise stated